The use of data from the real world to address clinical and policy-relevant questions that
cannot be answered using data from clinical trials is garnering increased interest. Indeed …

Despite women being disproportionally affected by cancer deaths at young ages, there are
no global estimates of the resulting maternal orphans, who experience health and education …

Breast cancer is the leading cancer diagnosis and second most common cause of cancer
deaths in sub‐Saharan Africa (SSA). Yet, there are few population‐level survival data from …

Background Breast cancer is the second leading cause of death from cancer in women in
sub-Saharan Africa, yet there are few well characterised large-scale survival studies with …

Breast cancer is the most common malignancy among women worldwide. The current
COVID-19 pandemic represents an unprecedented challenge leading to care disruption …

Background Poor breast cancer survival in low-income and middle-income countries
(LMICs) can be attributed to advanced-stage presentation and poor access to systemic …

Background Improving breast cancer survival in sub-Saharan Africa (SSA) is urgently
needed, requiring early diagnosis and improved access to treatment. However, data on the …

Background Women with breast cancer in sub-Saharan Africa are commonly diagnosed at
advanced stages. In Tanzania, more than 80% of women are diagnosed with stage III or IV …

Diagnosing cancer earlier can enable timely treatment and optimize outcomes. Worldwide,
national cancer control plans increasingly encompass early diagnosis programs for …

Most breast cancer patients in sub‐Saharan Africa are diagnosed at advanced stages after
prolonged symptomatic periods. In the multicountry African Breast Cancer‐Disparities in …